BioMed ENT showcases at AAO-HNSF
San Antonio, Texas – October1, 2018 – BioMed ENT, Inc. will exhibit at the AAO-HNSF annual meeting in Atlanta, Georgia between October 7 and 10, 2018. The recently incorporated company will present its range of regenerative solutions.
BioMed ENT has developed a range of regenerative solutions for otolaryngology and will present these at the congress which is also the launch of the company. BioMed ENT has been set up as a subsidiary of BioMed Elements, a company active in the development and manufacturing of biomaterials in various surgical applications.
“Setting up BioMed ENT is the first step of our activities in the United States and will offer the opportunity to otolaryngologists to have access to innovative regenerative solutions which are tailored to their needs,” according to Chief Executive Officer Tonny Voermans. The range consists of products for rhinoplasty and tympanoplasty surgery and are of the highest quality.
The company is based in San Antonio, Texas, as this is in the heart of the biomedical triangle in Texas. “Our current focus is to inform our partners on the advantages of using BioMed ENT’s products and provide data. We are setting up a medical advisory board who can further guide our company.”
BioMed ENT will exhibit at booth 2553 and welcomes all who want to know more about the range of innovative regenerative solutions.
Biologics range of BioMed ENT available from now
BioMed ENT will introduce its innovative range of biologics suitable for myringoplasty and rhinoplasty. In cooperation with US and European surgeons and partners, we have developed a range of the highest quality biologics which enable surgeons to have better and faster outcomes.
The range is available in the US and Middle East and is expected to be launched in Europe in March 2019. BioMed ENT is expanding its distribution network to introduce these biological solutions to surgeons and present them the advantages of this range.